catalyst
as of 2026-07-01A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely — primary completion
at a glance
2022-10-26 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.
Event
What
A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely — primary completion
Type
Trial Readout
Date
2022-10-26
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here